Skip to content

Study on Early Assessment of Chemotherapy-Induced Peripheral Neuropathy in Patients with Ovarian Cancer and Intervention Effect of Cold Compress on Extremities

Study on Early Assessment of Chemotherapy-Induced Peripheral Neuropathy in Patients with Ovarian Cancer and Intervention Effect of Cold Compress on Extremities

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074397
Enrollment
Unknown
Registered
2023-08-04
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Intervention group - limb cold compress group:Cold compress treatment
control group:Routine chemotherapy care

Sponsors

The Fourth Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
62 Years to 39 Years

Inclusion criteria

Inclusion criteria: Meets the diagnostic criteria of the International Federation of Obstetrics and Gynecology (FIGO) for ovarian cancer; Full treatment at our hospital; Expected survival time>3 months; The tumor did not experience distant metastasis; Possess complete cognitive understanding ability.

Exclusion criteria

Exclusion criteria: Having factors such as hearing impairment, language impairment, unclear consciousness, or mental illness that prevent communication with them; Withdrawal from treatment midway; Existence of other serious organic diseases; Tumor recurrence; Received other treatment measures during the treatment process; Missing clinical data; Peripheral neuropathy caused by diabetes, infection and other reasons; Unable to evaluate clinical treatment effectiveness.

Design outcomes

Primary

MeasureTime frame
morbidity;Total Neuropathy Score - Clinical Version;Motor nerve conduction velocity;Sensory nerve conduction velocity;Nerve growth factor;Nerve growth factor;

Countries

China

Contacts

Public ContactLin Zhu

The Fourth Hospital of Hebei Medical University

zhulin3169161@163.com+86 185 3117 9208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026